ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 53 filers reported holding ACUMEN PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,677,214 | +75.1% | 645,112 | +323.2% | 0.02% | +61.5% |
| Q3 2022 | $1,529,000 | +180.6% | 152,429 | +31.4% | 0.01% | +160.0% |
| Q2 2022 | $545,000 | +61.2% | 116,029 | +34.1% | 0.01% | +66.7% |
| Q1 2022 | $338,000 | -42.2% | 86,543 | 0.0% | 0.00% | -40.0% |
| Q4 2021 | $585,000 | – | 86,543 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sands Capital Ventures, LLC | 3,417,075 | $13,361,000 | 2.79% |
| GREAT POINT PARTNERS LLC | 928,282 | $3,630,000 | 0.88% |
| RA Capital Management | 9,770,773 | $38,204,000 | 0.83% |
| GUARDIAN POINT CAPITAL, LP | 500,000 | $1,955,000 | 0.71% |
| Deep Track Capital, LP | 2,599,098 | $10,162,000 | 0.65% |
| WMS Partners, LLC | 181,068 | $708,000 | 0.10% |
| Perceptive Advisors | 596,942 | $2,334,000 | 0.05% |
| BVF INC/IL | 289,663 | $1,133,000 | 0.04% |
| MOORE CAPITAL MANAGEMENT, LP | 358,482 | $1,402,000 | 0.04% |
| Woodline Partners LP | 501,236 | $1,960,000 | 0.03% |